Found: 11
Select item for more details and to access through your institution.
Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.92678
- By:
- Publication type:
- Article
Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies.
- Published in:
- Nature Communications, 2023, p. 1, doi. 10.1038/s41467-023-43429-2
- By:
- Publication type:
- Article
A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis.
- Published in:
- AAPS Journal, 2022, v. 24, n. 1, p. 1, doi. 10.1208/s12248-021-00637-2
- By:
- Publication type:
- Article
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50031-4
- By:
- Publication type:
- Article
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 496, p. N.PAG, doi. 10.1126/scitranslmed.aav5989
- By:
- Publication type:
- Article
p95HER2-T cell bispecific antibody for breast cancer treatment.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 461, p. 1, doi. 10.1126/scitranslmed.aat1445
- By:
- Publication type:
- Article
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/1023490
- By:
- Publication type:
- Article
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 129, doi. 10.1007/s00262-016-1927-1
- By:
- Publication type:
- Article
Antitumour activity of the glycoengineered type II anti- CD20 antibody obinutuzumab ( GA101) in combination with the MDM2-selective antagonist idasanutlin ( RG7388).
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 5, p. 461, doi. 10.1111/ejh.12756
- By:
- Publication type:
- Article
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2016, v. 29, n. 10, p. 457, doi. 10.1093/protein/gzw040
- By:
- Publication type:
- Article
Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol.
- Published in:
- Medical Microbiology & Immunology, 2008, v. 197, n. 2, p. 185, doi. 10.1007/s00430-008-0091-4
- By:
- Publication type:
- Article